Education:

2007-2011 Bachelor of Life Science, Xiamen University

2011-2016 Doctor of Philosophy (Biology), School of Life Science, Tsinghua University

Professional Positions:

2017-2021 Research Associate, Harvard Medical School and Boston Children‘s Hospital, USA

2021-2023 Scientist, Harvard Medical School and Boston Children‘s Hospital, USA

2023-present Assistant Professor

Center for Infection Biology, School of Basic Medical Sciences, Tsinghua University

Research Areas:

The research and development of vaccines and therapeutic antibodies; the molecular mechanisms for B cell receptor diversification. Current research interests include exploring the immune response triggered by viral infections using humanized mouse models, studying and reshaping the co-evolutionary process between high-mutation RNA viruses and the host immune system, thereby developing innovative vaccines and broadly neutralizing antibodies. We are also interested in the molecular mechanisms of B cell receptor diversification and the potential role of non-coding RNA involved.

Honors and Awards:

➢ 2021 The 9th Norman L. Letvin Early Career Investigator

➢ 2016 Ray Wu Prize

Selected Publications:

1.S. Luo*†, J. Zhang†, A. J. B. Kreutzberger†, A. Eaton, R. J. Edwards, C. Jing, H. Q. Dai, G. D. Sempowski, K. Cronin, R. Parks, A. Y. Ye, K. Mansouri, M. Barr, N. Pishesha, A. C. Williams, L. Vieira Francisco, A. Saminathan, H. Peng, H. Batra, L. Bellusci, S. Khurana, S. M. Alam, D. C. Montefiori, K. O. Saunders, M. Tian, H. Ploegh, T. Kirchhausen*, B. Chen*, B. F. Haynes*, F. W. Alt*, An antibody from single human VH-rearranging mouse neutralizes all SARS-CoV-2 variants through BA.5 by inhibiting membrane fusion. Sci Immunol 7, eadd5446 (2022). (†co-first author) (*co-corresponding author)

2.S. Luo†, C. Jing†, A. Y. Ye†, S. Kratochvil, C. A. Cottrell, J. Koo, A. C. Williams, L. V. Francisco, H. Batra, E. Lamperti, O. Kalyuzhniy, Y. Zhang, A. Barbieri, J. P. Manis, B. F. Haynes, W. R. Schief, F. D. Batista, M. Tian, F. W. Alt, Humanized V(D)J-rearranging and TdT-expressing Mouse Vaccine Models with Physiological HIV-1 Broadly Neutralizing Antibody Precursors. Proc Natl Acad Sci, U S A 120, e2217883120 (2023) (†co-first author)

3.C. Cottrell†, X. Hu†, J. Lee† , P. Skog, S. Luo, C. Flynn, K. McKenney, J. Hurtado, O. Kalyuzhniy, A. Liguori, J. Willis, E. Landais, S. Raemisch, X. Chen, S. Baboo, S. Himansu, J. Diedrich, H. Duan, C. Cheng, T. Schiffner, D. Bader, D. Kulp, R. Tingle, E. Georgeson, S. Eskandarzadeh, N. Alavi, D. Lu, T. Sincomb, M. Kubitz, T. Mullen, J. Yates III, J. Paulson, J. Mascola, F. Alt, B. Briney, D. Sok, and W. Schief, Heterologous prime-boost vaccination drives early maturation of HIV broadly neutralizing antibody precursors in a humanized mouse model. Science Translational Medicine (2024)

4.X. Han†, S. Luo†, G. Peng, J. Y. Lu, G. Cui, L. Liu, P. Yan, Y. Yin, W. Liu, R. Wang, J. Zhang, S. Ai, Z. Chang, J. Na, A. He, N. Jing, X. Shen, Mouse knockout models reveal largely dispensable but context-dependent functions of lncRNAs during development. J Mol Cell Biol 10, 175-178 (2018). (†co-first author)

5.P. Yan, S. Luo, J. Y. Lu, X. Shen, Cis- and trans-acting lncRNAs in pluripotency and reprogramming. Curr Opin Genet Dev 46, 170-178 (2017).

6.S. Luo, J. Y. Lu, L. Liu, Y. Yin, C. Chen, X. Han, B. Wu, R. Xu, W. Liu, P. Yan, W. Shao, Z. Lu, H. Li, J. Na, F. Tang, J. Wang, Y. E. Zhang, X. Shen, Divergent lncRNAs Regulate Gene Expression and Lineage Differentiation in Pluripotent Cells. Cell Stem Cell 18, 637-652 (2016).